Market Pulse Archives

Jan. 3, 2022, 2:24 p.m. EST

Genprex stock more than doubles on very heavy volume after FTD granted for cancer treatment

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Genprex Inc. (GNPX)
  • X
    Merck & Co. Inc. (MRK)
  • X
    iShares Biotechnology ETF (IBB)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Genprex Inc. /zigman2/quotes/209629233/composite GNPX +3.31% skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration for use in combination with Merck & Co. Inc.'s /zigman2/quotes/209956077/composite MRK +0.74% cancer treatment Keytruda. Trading volume exploded to 163.9 million shares, compared with the full-day average of about 476,600 shares, and enough to make the stock the most actively traded on major U.S. exchanges. The company said the FTD is for use in patients with histologically confirmed unresectable stage III or IV non-small cell lung cancer (NSCLC) whose disease progressed after treatment with Keytruda. "This Fast Track Designation is an important step in our efforts to accelerate clinical development of REQORSA and another validation of the potential of REQORSA to treat the unmet medical need of patients with late-stage NSCLC," said Genprex Chief Executive Rodney Varner. The stock, which closed at a near two-year low of $1.21 as recently as Dec. 29, has now gained 7.0% over the past three months, while the iShares Biotechnology ETF /zigman2/quotes/206189322/composite IBB +2.85% has lost 4.6% and the S&P 500 /zigman2/quotes/210599714/realtime SPX +2.02% has advanced 9.9%.

/zigman2/quotes/209629233/composite
US : U.S.: Nasdaq
$ 1.56
+0.05 +3.31%
Volume: 103,822
May 17, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$72.33 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 93.00
+0.68 +0.74%
Volume: 17.58M
May 17, 2022 4:03p
P/E Ratio
16.64
Dividend Yield
2.97%
Market Cap
$233.46 billion
Rev. per Employee
$799,500
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 116.52
+3.23 +2.85%
Volume: 2.32M
May 17, 2022 4:15p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,088.85
+80.84 +2.02%
Volume: 2.46B
May 17, 2022 4:54p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.